Investor Relations

Overview

MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

Read More
Webcast ImageWebcast
MyoKardia - Review Phase 3 EXPLORER-HCM Trial Design (Replay)
May 21, 2018 at 8:30 a.m. ET
MyoKardia - Review Phase 3 EXPLORER-HCM Trial Design
Monday, May 21, 2018 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Recent Press Releases

Upcoming Events

There are currently no events scheduled.